Radiation plus at-home tumor device for locally advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether combining targeted radiation with an at-home “tumor treating fields” device can better control locally advanced pancreatic cancer. It may help by attacking cancer cells in more than one way after prior chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed locally advanced pancreatic adenocarcinoma (a specific type of pancreatic cancer), not pancreatic cysts or other types
- Your cancer has not spread to distant organs (no distant metastasis) and can be treated with radiation in the chest/abdomen area
- You finished at least about 3 months of prior pancreas cancer chemotherapy (like FOLFIRINOX or gemcitabine/nab-paclitaxel) and scans do not show distant progression
- You can do daily life with limited help (ECOG performance status 0–1)
- You meet blood and liver levels needed for treatment (for example, hemoglobin, neutrophils, platelets, bilirubin, and AST/ALT thresholds)
- You can safely use the at-home tumor device (NovoTTF-100L) and have no reasons you can’t get MRI scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of targeted radiation and two oral drugs (defactinib and avutometinib) for people with advanced pancreatic cancer that hasn't spread to distant organs. It may be an option if you've already had at least 2 months of chemo and your cancer is still locally advanced or borderline resectable.
This trial tests a new type of radiation that adapts in real time using MRI scans. It is for people with locally advanced pancreatic cancer that has not spread, and who have already completed at least 4 cycles of chemotherapy.
This trial tests a new way to deliver a drug called amifostine (XER-001) alongside intense radiation therapy (SBRT) for people with locally advanced pancreatic cancer that can't be surgically removed. The goal is to see if it's safe and effective at protecting healthy tissue while targeting the tumor.
This trial tests a combination of chemotherapy drugs plus a portable TTF device (TTF-100L) to treat pancreatic cancer that has spread to the liver. It may help by trying to shrink or control the cancer in people who haven’t already had treatment specifically for stage IV metastatic disease.
This Phase 2 trial tests giving specific chemotherapy in sequence, then using MRI-guided focused radiation to treat locally advanced, non-removable pancreatic cancer. It may help shrink or control the tumor while aiming radiation more precisely using MRI.
This trial tests whether a home-wearable tumor-treating device (Tumor Treating Fields) combined with gemcitabine and albumin-bound paclitaxel works better as first treatment for locally advanced pancreatic cancer. It may help by targeting cancer cells while also using standard chemotherapy.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.